https://pmc.ncbi.nlm.nih.gov/articles/PMC10798864/
Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in...
The benefit of continuing 5-aminosalicylic acid [5-ASA] treatment when escalating to advanced therapies in patients with inflammatory bowel disease [IBD] is...
5 aminosalicylic acid
https://pmc.ncbi.nlm.nih.gov/articles/PMC6430391/
Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative...
It is well known that 5-aminosalicylic acid (5-ASA) is the standard first-line treatment for ulcerative colitis (UC). Medication adherence is an important...
5 aminosalicylic acid
https://pmc.ncbi.nlm.nih.gov/articles/PMC7043877/
Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative...
This study is aimed to design and synthesize a prodrug of 5-aminosalicylic acid and evaluate its ameliorative effect on experimental ulcerative colitis (UC)....
5 aminosalicylic acid
https://pmc.ncbi.nlm.nih.gov/articles/PMC4042117/
Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of...
Pharmacotherapy based on 5-aminosalicylic acid (5-ASA) is a preferred treatment for ulcerative colitis, but variable patient response to this therapy is...
5 aminosalicylic acid